Charles Schwab Investment Management »

Arcutis Biotherapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 571k 3.23
2023-09-30 $2.0M 384k 5.31
2023-06-30 $3.1M 330k 9.53
2023-03-31 $3.3M 303k 11.00
2022-12-31 $4.5M 302k 14.80
2022-09-30 $5.6M 291k 19.11
2022-06-30 $4.6M 217k 21.31
2022-03-31 $3.9M 201k 19.26
2021-12-31 $4.1M 199k 20.74
2021-09-30 $4.7M 196k 23.89
2021-06-30 $5.3M 193k 27.29
2021-03-31 $5.2M 180k 28.93
2020-12-31 $4.0M 141k 28.13
2020-09-30 $3.2M 111k 29.31
2020-06-30 $2.1M 68k 30.24
2020-03-31 $657k 22k 29.84